About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Division of Hematology
›
top-articles
Division of Hematology
51
(top 2%)
papers
1.9K
(top 1%)
citations
24
(top 1%)
h
-index
44
(top 1%)
g
-index
51
all documents
1.9K
doc citations
636
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Characterization of Genetically Altered, Interleukin 2-Independent Natural Killer Cell Lines Suitable for Adoptive Cellular Immunotherapy
Human Gene Therapy
1999
177
2
Thy-1 expression is linked to functional properties of primitive hematopoietic progenitor cells from human umbilical cord blood
Blood
1994
164
3
Treatment of cancer-associated thrombosis
Blood
2013
158
4
Management of cancer‐associated thrombosis in patients with thrombocytopenia: guidance from the SSC of the ISTH
Journal of Thrombosis and Haemostasis
2018
140
5
Lymphoproliferative disorders following allogeneic bone marrow transplantation: the Vancouver experience
Bone Marrow Transplantation
1998
101
6
Selective Expansion of Primitive Normal Hematopoietic Cells in Cytokine-Supplemented Cultures of Purified Cells From Patients With Chronic Myeloid Leukemia
Blood
1997
91
7
A cytotoxic NK-cell line (NK-92) for ex vivo purging of leukemia from blood
Biology of Blood and Marrow Transplantation
1996
84
8
Clinical, haematological and cytogenetic features in 24 patients with structural rearrangements of the Q arm of chromosome 3
British Journal of Haematology
1993
74
9
Characterization of functionally distinct subpopulations of CD34+ cord blood cells in serum-free long-term cultures supplemented with hematopoietic cytokines
Blood
1993
71
10
Characterization of functionally distinct subpopulations of CD34+ cord blood cells in serum-free long-term cultures supplemented with hematopoietic cytokines
Blood
1993
67
11
Treatment of Steroid-Resistant Acute Graft-Versus-Host Disease with Rabbit Antithymocyte Globulin
Journal of Hematotherapy and Stem Cell Research
2000
60
12
Hodgkin's Lymphoma in Adolescents
Journal of Clinical Oncology
2006
55
13
Multicolor fluorescence in situ hybridization with peptide nucleic acid probes for enumeration of specific chromosomes in human cells
Genes Chromosomes and Cancer
2001
52
14
High incidence of extramedullary relapse of AML after busulfan/cyclophosphamide conditioning and allogeneic stem cell transplantation
Bone Marrow Transplantation
1998
50
15
Shifting to outpatient management of acute myeloid leukemia: a prospective experience
Annals of Oncology
2006
47
16
Long-Term Outcome of Myeloablative Allogeneic Stem Cell Transplantation for Multiple Myeloma
Biology of Blood and Marrow Transplantation
2007
44
17
Chemoresistance can be overcome with high-dose chemotherapy and autologous stem-cell transplantation for relapsed and refractory Hodgkin lymphoma
Annals of Oncology
2014
41
18
Thy-1 expression is linked to functional properties of primitive hematopoietic progenitor cells from human umbilical cord blood
Blood
1994
35
19
Adult Dual Umbilical Cord Blood Transplantation Using Myeloablative Total Body Irradiation (1350 cGy) and Fludarabine Conditioning
Biology of Blood and Marrow Transplantation
2011
32
20
Stress, social rank and leukocyte telomere length
Aging Cell
2006
29
21
Azathioprine‐associated acute myeloid leukemia in a patient with Crohn's disease and thiopurine
S
‐methyltransferase deficiency
American Journal of Hematology
2008
29
22
Gas-chromatographic analysis of busulfan for therapeutic drug monitoring
Cancer Chemotherapy and Pharmacology
1993
28
23
Patient Experience of Living With Cancer‐Associated Thrombosis in Canada (PELICANADA)
Research and Practice in Thrombosis and Haemostasis
2020
26
24
Oral fludarabine and rituximab as initial therapy for chronic lymphocytic leukemia or small lymphocytic lymphoma: population-based experience matches clinical trials
Leukemia and Lymphoma
2012
24
25
Allogeneic Hematopoietic Stem Cell Transplantation Is an Effective Salvage Therapy for Patients with Chronic Myeloid Leukemia Presenting with Advanced Disease or Failing Treatment with Tyrosine Kinase Inhibitors
Biology of Blood and Marrow Transplantation
2015
24
26
Immunotherapy after bone marrow transplantation
Bone Marrow Transplantation
1991
24
27
IPSS Poor-Risk Karyotype as a Predictor of Outcome for Patients with Myelodysplastic Syndrome following Myeloablative Stem Cell Transplantation
Biology of Blood and Marrow Transplantation
2009
23
28
Efficacy and Safety of Busulfan-Based Conditioning Regimens for Multiple Myeloma
Oncologist
2013
23
29
Characterization of functionally distinct subpopulations of CD34+ cord blood cells in serum-free long-term cultures supplemented with hematopoietic cytokines
Blood
1993
21
30
COSIMO – patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional study
Thrombosis Journal
2018
20
31
Bone marrow transplantation for adults with acute leukaemia and 11q23 chromosomal abnormalities
British Journal of Haematology
1998
15
32
The Role of Erythropoietin and Other Growth Factors in Transfusion Medicine
Transfusion Medicine Reviews
1991
13
33
Anticoagulation Treatment in Cancer-Associated Venous Thromboembolism: Assessment of Patient Preferences Using a Discrete Choice Experiment (COSIMO Study)
Thrombosis and Haemostasis
2021
12
34
Paraneoplastic Erythropoietin-Induced Polycythemia Associated With Small Lymphocytic Lymphoma
Journal of Clinical Oncology
2006
11
35
Optimal duration of imatinib treatment/deep molecular response for treatment‐free remission after imatinib discontinuation from a Canadian tyrosine kinase inhibitor discontinuation trial
British Journal of Haematology
2021
10
36
Patient-reported outcomes associated with changing to rivaroxaban for the treatment of cancer-associated venous thromboembolism – The COSIMO study
Thrombosis Research
2021
10
37
Selective Expansion of Primitive Normal Hematopoietic Cells in Cytokine-Supplemented Cultures of Purified Cells From Patients With Chronic Myeloid Leukemia
Blood
1997
10
38
Analysis of BCR–ABL1 tyrosine kinase domain mutational spectra in primitive chronic myeloid leukemia cells suggests a unique mutator phenotype
Leukemia
2010
9
39
Spontaneous remission of multilobated non-Hodgkin lymphoma
American Journal of Hematology
1992
7
40
Sorafenib is effective for imatinib-resistant FIP1L1/PDGFRA T674I mutation-positive acute myeloid leukemia with eosinophilia
Leukemia and Lymphoma
2013
7
41
Direct Oral Anticoagulants in Cancer Patients
Seminars in Thrombosis and Hemostasis
2019
7
42
Interleukin-6 does not support interleukin-2 induced generation of human lymphokine-activated killer cells
Cancer Immunology, Immunotherapy
1991
5
43
RETURN TO DURABLE DONOR HAEMATOPOIESIS AFTER BLAST PHASE RELAPSE OF CHRONIC MYELOID LEUKAEMIA FOLLOWING MARROW TRANSPLANTATION
British Journal of Haematology
1992
4
44
Thy-1 expression is linked to functional properties of primitive hematopoietic progenitor cells from human umbilical cord blood
Blood
1994
3
45
Development of a new clinical index to easily assess frailty of elderly patients with multiple myeloma in Asian population
Scientific Reports
2021
3
46
Canadian chronic myeloid leukemia outcomes post-transplant in the tyrosine kinase inhibitor era
Leukemia Research
2018
2
47
Successful Allogeneic Hematopoietic Cell Transplantation Using Flu-Bu-ATG Conditioning for “Mono-MAC Syndrome” [GATA2 Deficiency]
Biology of Blood and Marrow Transplantation
2016
1
48
Updates from the 2017 American Society of Hematology Annual Meeting: Practice-Changing Studies in Untreated Chronic Lymphocytic Leukemia
Current Oncology
2018
0
49
Long Term Follow-Up Results for Patients with Hodgkin Lymphoma after First Remission of Longer Than Ten Years: A Population Based Study of 954 Patients from the British Columbia Cancer Agency.
Blood
2006
0
50
Incidence and Outcomes of Catheter Related Thrombosis in Acute Leukemia: Single Centre Experience
Blood
2016
0
site/software ©
exaly
; All materials licenced under
CC by-SA
.